Raman Bahal
Associate Professor/Pharmaceutical Science

Are you Raman Bahal?

How to update your information.
Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin
2024
Prajith Stephen, Jordyn Belcourt, Alexis Frankel, Alicia Zongxun Wang, Sherouk M. Tawfik, Milan Shah, Theodore Rasmussen, Xiao Bo Zhong, Jing Jin, Anagha Gogate, Jose E Manautou, Aarush Kolli, Raman Bahal, Matthew Chalon, Holly Kolmel
Research Type: Other Scholarly Work

Multivalent Lactobionic Acid and N-Acetylgalactosamine-Conjugated Peptide Nucleic Acids for Efficient In Vivo Targeting of Hepatocytes
2023
Anisha Gupta, José E. Manautou, Vikas Kumar, Aniket Wahane, Raman Bahal
Research Type: Journal Article

microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis.
2023
C Fernández-Hernando, S Ding, K S Rose, J C Schupp, M Chioccioli, G DeIuliis, G Ibarra, I Rosas, C S Dela Cruz, Xiaoyang Liu, C Cosmos, Jr, J E McDonough, T Bärnthaler, F Ahangari, J A Villalba Nunez, N R Aurelien, N L Price, S P Pradeep, Raman Bahal, A Prasse, Jung-Min Kim, T S Adams, S Malik, N Omote, C Ryu, N Kaminski, L Sharma
Research Type: Journal Article

Next-generation poly-L-histidine formulations for miRNA mimic delivery
2023
Raman Bahal, Vishal Kasina, Aniket Wahane, Lin Yang, Chung Hao Liu, Mu Ping Nieh, Mu-ping Nieh
Research Type: Journal Article

Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics.
2023
Raman Bahal, S P Pradeep, F J Slack, S Malik
Research Type: Journal Article

Targeting genomic DNA for cancer therapy, Invention disclosure submitted
2023
Research Type: Patent and Intellectual Property

Discoidal nano universal platform for efficient delivery of PNAs
2023
Research Type: Patent and Intellectual Property

Nanoparticle-mediated genome editing in single-cell embryos via peptide nucleic acids.
2022
Raman Bahal, P M Glazer, A S Ricciardi, W M Saltzman, R Putman, E Quijano
Research Type: Journal Article

New Technologies Bloom Together for Bettering Cancer Drug Conjugates.
2022
S Edalatian Zakeri, Y Jin, Andrew Wiemer, Raman Bahal
Research Type: Journal Article

Head on Comparison of Self- and Nano-assemblies of Gamma Peptide Nucleic Acid Amphiphiles.
2022
C H Liu, S Krueger, K C Shih, Mu-ping Nieh, S Malik, V Kumar, Raman Bahal
Research Type: Journal Article

Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression.
2022
A Moshnikova, N L Price, O A Andreev, N Rotllan, C Fernández-Hernando, Y K Reshetnyak, Y Suárez, M M Sadeghi, Raman Bahal, Xinxuan Zhang, W Zhong, E Araldi, S Malik, A Canfrán-Duque, Jianjun Sun, J Toczek
Research Type: Journal Article

Adverse Drug Reactions and Toxicity of the Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
2022
Kristy Zhang, Hangyu Wu, Rajvi Parikh, xiaobo zhong, Theodore Rasmussen, Feryal Alhamadani, Jose E Manautou, Raman Bahal
Research Type: Journal Article

Serine-γPNA, Invader probes, and chimeras thereof: three probe chemistries that enable sequence-unrestricted recognition of double-stranded DNA.
2022
Raman Bahal, R G Emehiser, C Shepard, S Karmakar, K Dhuri, P J Hrdlicka
Research Type: Journal Article

Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
2022
Sunna Liu, xiaobo zhong, Sreenidhi Nair, Theodore Rasmussen, Anna Liu, Anagha Gogate, Raman Bahal, Julia M Migliorati, Jose E Manautou
Research Type: Journal Article

γ Peptide Nucleic Acid-Based miR-122 Inhibition Rescues Vascular Endothelial Dysfunction in Mice Fed a High-Fat Diet.
2022
K Irani, Q Li, V Kumar, Yusun Kim, J S Jacobs, A Vikram, Raman Bahal, K Dhuri, R R Gaddam
Research Type: Journal Article

Casimersen for the treatment of Duchenne muscular dystrophy.
2022
Raman Bahal, S P Pradeep, Jose E Manautou, V Kasina, A P Laddha, S E Zakeri
Research Type: Journal Article

Simultaneous targeting of multiple oncomiRs with phosphorothioate or PNA-based anti-miRs in lymphoma cell lines
2022
Raman Bahal, Karishma Dhuri, Xiaobo Zhong, Sai Pallavi Pradeep, Frank J Slack, Jason Shi, Anisha Gupta, Eleni Anastasiadou
Research Type: Journal Article

Nephrotoxicity of marketed antisense oligonucleotide drugs
2022
Feryal Alhamadani, Rajvi Parikh, Theodore Rasmussen, Evan M McCabe, SooWan Lee, Xiaobo Zhong, Jose E Manautou, Aniket Wahane, Hangyu Wu, Raman Bahal, Kristy Zhang
Research Type: Journal Article

Nanoparticle delivery systems for substance use disorder.
2022
R J Mownn, Raman Bahal, V Kasina, Gregory Sartor
Research Type: Journal Article

Nedosiran, a Candidate siRNA Drug for the Treatment of Primary Hyperoxaluria: Design, Development, and Clinical Studies
2022
Theodore Rasmussen, Jenny Zhao, Julia M. Migliorati, Raman Bahal, Jose E Manautou, Milan Shah, Anna Liu, Sherouk M. Tawfik, Xiao Bo Zhong
Research Type: Other Scholarly Work